Prakt. lékáren. 2011; 7(1): 20-23
Erectile dysfunction treatment
- TH klinika, Praha
The article presents the fundamentals of treatment for erectile dysfunction reviewing the experience from the first decade of existence
of PDE-5 inhibitors. Previously published facts are summarized supplemented with new knowledge in order to provide a most accurate
outline for everyday use in the present day.
injections, prostaglandines, psychotherapy.
Keywords: erectile dysfunction, pharmacotherapy, inhibitors of phosphodiesterasis 5, treatment ad hoc and daily dosage, intracavernal
Published: February 1, 2011 Show citation
References
- Trojan O. Možnosti léčby erektilní dysfunkce: kde jsme a kam se ubíráme? Causa Subita 2003.
- Brock G. Issues in the Assessment and Treatment of Erectile Dysfunction: Individualizing and Optimizing Therapy for the, ,Silent Majority" CME/WEB.
- Heráček J. Farmakoterapie erektilní dysfunkce - 1. část, Farmakoterapeutické informace, 2004; 13(3): 1-4.
- Taylor J, et al. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors, BJU International 2009.
Go to original source... - Montorsi F. Ústní sdělení - Symposium o léčbě ED, Kongres EAU, březen 2008.
- De Busc R, Drory R, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease: Recommendation of the Priceton Consensus panel. Am J Cardiol 2000; 86: 175-181. Go to original source...
Go to PubMed...